DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
CNY 16.16
(0.56%)
CNY 16.16
(0.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 24.12 Billion CNY | 15.75% |
| 2022 | 20.84 Billion CNY | 20.22% |
| 2021 | 17.33 Billion CNY | 40.58% |
| 2020 | 12.33 Billion CNY | 42.21% |
| 2019 | 8.67 Billion CNY | 32.66% |
| 2018 | 6.53 Billion CNY | 12.27% |
| 2017 | 5.82 Billion CNY | 62.64% |
| 2016 | 3.58 Billion CNY | 34.67% |
| 2015 | 2.65 Billion CNY | 12.4% |
| 2014 | 2.36 Billion CNY | 40.71% |
| 2013 | 1.68 Billion CNY | 68.67% |
| 2012 | 996.5 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 25.87 Billion CNY | 1.53% |
| 2024 Q1 | 25.36 Billion CNY | 5.15% |
| 2024 Q2 | 25.48 Billion CNY | 0.48% |
| 2023 Q2 | 20.83 Billion CNY | -1.53% |
| 2023 Q3 | 21.43 Billion CNY | 2.89% |
| 2023 Q4 | 24.12 Billion CNY | 12.56% |
| 2023 FY | 24.12 Billion CNY | 15.75% |
| 2023 Q1 | 21.15 Billion CNY | 1.51% |
| 2022 Q4 | 20.84 Billion CNY | 14.22% |
| 2022 Q3 | 18.24 Billion CNY | 1.62% |
| 2022 Q1 | 17.71 Billion CNY | 2.22% |
| 2022 FY | 20.84 Billion CNY | 20.22% |
| 2022 Q2 | 17.95 Billion CNY | 1.33% |
| 2021 Q4 | 17.33 Billion CNY | 7.75% |
| 2021 FY | 17.33 Billion CNY | 40.58% |
| 2021 Q2 | 15.58 Billion CNY | 0.48% |
| 2021 Q1 | 15.5 Billion CNY | 25.74% |
| 2021 Q3 | 16.08 Billion CNY | 3.26% |
| 2020 Q1 | 9.16 Billion CNY | 5.69% |
| 2020 Q2 | 9.03 Billion CNY | -1.46% |
| 2020 Q4 | 12.33 Billion CNY | 24.32% |
| 2020 FY | 12.33 Billion CNY | 42.21% |
| 2020 Q3 | 9.91 Billion CNY | 9.83% |
| 2019 Q1 | 6.91 Billion CNY | 5.74% |
| 2019 FY | 8.67 Billion CNY | 32.66% |
| 2019 Q2 | 7.69 Billion CNY | 11.37% |
| 2019 Q4 | 8.67 Billion CNY | 9.64% |
| 2019 Q3 | 7.9 Billion CNY | 2.75% |
| 2018 Q1 | 5.66 Billion CNY | -2.73% |
| 2018 Q2 | 5.76 Billion CNY | 1.85% |
| 2018 Q3 | 6.37 Billion CNY | 10.46% |
| 2018 Q4 | 6.53 Billion CNY | 2.59% |
| 2018 FY | 6.53 Billion CNY | 12.27% |
| 2017 Q4 | 5.82 Billion CNY | 9.97% |
| 2017 Q2 | 3.98 Billion CNY | 7.74% |
| 2017 Q3 | 5.29 Billion CNY | 32.75% |
| 2017 Q1 | 3.7 Billion CNY | 3.4% |
| 2017 FY | 5.82 Billion CNY | 62.64% |
| 2016 FY | 3.58 Billion CNY | 34.67% |
| 2016 Q4 | 3.58 Billion CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2015 FY | 2.65 Billion CNY | 12.4% |
| 2015 Q4 | 2.65 Billion CNY | 0.0% |
| 2015 Q1 | 2.47 Billion CNY | 0.0% |
| 2015 Q2 | 2.47 Billion CNY | 0.0% |
| 2014 FY | 2.36 Billion CNY | 40.71% |
| 2013 FY | 1.68 Billion CNY | 68.67% |
| 2012 FY | 996.5 Million CNY | 0.0% |